Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-28

Clinical Trial Update: AGItated Patients Management: intraNASAL Midazolam vs Intramuscular Loxapine [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intranasal midazolam to intramuscular loxapine for agitation in emergence delirium was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loxapine (intramuscular) (loxapine)
  • Midazolam (intranasal) (midazolam)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Emergence Delirium | Phase 3 | Status: TERMINATED